logo
ResearchBunny Logo
Commensal *Hafnia alvei* strain reduces food intake and fat mass in obese mice—a new potential probiotic for appetite and body weight management

Health and Fitness

Commensal *Hafnia alvei* strain reduces food intake and fat mass in obese mice—a new potential probiotic for appetite and body weight management

R. Legrand, N. Lucas, et al.

This exciting study reveals how *Hafnia alvei*, a ClpB-producing commensal bacterium, shows promise as a probiotic for managing appetite and body weight, potentially revolutionizing approaches to obesity treatment. The research, conducted by Romain Legrand and colleagues, uncovers significant findings through experiments on obese mice, paving the way for new probiotic interventions.

00:00
00:00
~3 min • Beginner • English
Abstract
Background/objectives Based on the recent identification of E.coli heat shock protein ClpB as a mimetic of the anorexigenic α-melanocyte stimulating hormone (α-MSH), the objective of this study was to preclinically validate Hafnia alvei, a ClpB-producing commensal bacterium as a potential probiotic for appetite and body weight management in overweight and obesity. Methods The involvement of enterobacterial ClpB in the putative anti-obesity effects was studied using ClpB-deficient E.coli. A food-grade H. alvei HA4597 strain synthetizing the ClpB protein with an α-MSH-like motif was selected as a candidate probiotic to be tested in ob/ob and high-fat diet (HFD)-fed obese and overweight mice. The relevance of the enterobacterial ClpB gene to human obesity was studied by in silico analysis of fecal metagenomes of 569 healthy individuals from the MetaHIT database. Results Chronic per os administration of native but not ClpB-deficient E.coli strain reduced body weight gain (p < 0.05) and daily meal frequency (p < 0.001) in ob/ob mice. Oral gavage of H. alvei for 18 and 46 days in ob/ob and HFD-fed obese mice, respectively, was well tolerated, reduced body weight gain and fat mass in both obesity models (p < 0.05) and decreased food intake in hyperphagic ob/ob mice (p < 0.001). Elevated fat tissue levels of phosphorylated hormone-sensitive lipase were detected in H. alvei-treated ob/ob mice (p < 0.01). Enterobacterial ClpB gene richness was lower in obese vs. non-obese humans (p < 0.0001) and correlated negatively with BMI in genera of Enterobacter, Klebsiella and Hafnia. Conclusions H. alvei HA4597 strain reduces food intake, body weight and fat mass gain in hyperphagic and obese mice. These data combined with low enterobacterial ClpB gene abundance in the microbiota of obese humans provide the rationale for using H. alvei as a probiotic for appetite and body weight management in overweight and obesity.
Publisher
International Journal of Obesity
Published On
Jan 07, 2020
Authors
Romain Legrand, Nicolas Lucas, Manon Dominique, Saida Azhar, Camille Deroissart, Marie-Anne Le Solliec, Julie Rondeaux, Séverine Nobis, Charlène Guérin, Fatima Léon, Jean-Claude do Rego, Nicolas Pons, Emmanuelle Le Chatelier, S. Dusko Ehrlich, Gregory Lambert, Pierre Déchelotte, Sergueï O. Fetissov
Tags
Hafnia alvei
probiotic
appetite management
body weight
obesity
ClpB
hyperphagic
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny